I got an invitation from ….

[Mik]

Given your involvement, I’d guess Alpha-1 will benefit.

[taiwan_girl]

@jon-nyc Good luck and make TNCR proud!!!

[89th]

Make sure to pack your jeans!

Seriously, that is cool. Would be nice to know what announcement it is so I can make the right trades. I mean, so that health wins!

[jodi]

Looking forward to hearing about it.

[Doctor Phibes]

Should be a cool experience. Just make sure you clean the toilet seat thoroughly before snorting coke.

[mark]

Looking forward to your take on it.

[jodi]

@Doctor-Phibes said in I got an invitation from ….:

Should be a cool experience. Just make sure you clean the toilet seat thoroughly before snorting coke.

Lol.

[Horace]

Cool. Say hi to RFK for me.

[LuFins Dad]

Don’t have the bear steak for lunch… Stick with the salad.

[jon-nyc]

From his lips to gods ears.

Of course there’s such a thing as ‘too good’ - for example, they could say that they’ll give conditional approval for rare disease treatments based on safety alone and let efficacy be proven in a P4 (post marketing) study. That sounds awesome, but the reality is insurance companies wouldn’t approve it considering it ‘experimental’.

What I’d like to see is them allow more flexibility with approvals based on biomarkers rather than clinical outcomes which can take much more time to demonstrate in some diseases.